<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13227">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01838707</url>
  </required_header>
  <id_info>
    <org_study_id>1976</org_study_id>
    <nct_id>NCT01838707</nct_id>
  </id_info>
  <brief_title>Postoperative Epidural Analgesia in Spine Fusion Surgery</brief_title>
  <official_title>Postoperative Epidural Analgesia in Spine Fusion Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <authority>Egypt: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      we aim to compare the analgesic effect of 0.125% bupivacaine HCL, 0.125% bupivacaine HCL +
      Morphine sulphate 3 mg, 0.125% bupivacaine HCL + Fentanyl 100 micro gram both at rest and
      mobilization maneuvers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Assessment of pain</measure>
    <time_frame>first 3 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
    <description>â€¢	Pain will be assessed using the VAS ranging from &quot;0&quot; (no pain) to &quot;10&quot; (worst imaginable pain). Pain will be evaluated at rest, while coughing, and during mobilization. Maneuvers of particular clinical importance for postoperative mobilization (alone and with help) will be chosen: Turning in bed, standing in front of the bed and walking, and using the toilet without help. The time needed until the patient can first successfully perform these maneuvers will be documented.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assessment of patients' satisfaction</measure>
    <time_frame>First 3 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
    <description>verbal rating score will be used (4 = very satisfied, 3 = satisfied, 2 = neutral, 1 = dissatisfied, and 0 = very dissatisfied).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>beta-endorphin</measure>
    <time_frame>1st postoperative day</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>3 serum samples for beta-endorphin will be taken 1st one preoperative base line , 2nd at VAS more than 3 at rest ,3rd when VAS less than 2 at rest</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.125% Bupivacaine HCL @ 4-5 ml/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine, Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.125% Bupivacaine HCL , Morphine sulphate 3 mg @ 3-5 ml/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine, Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.125% Bupivacaine HCL @ 4-5 ml/h</intervention_name>
    <arm_group_label>Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.125% Bupivacaine HCL , Morphine sulphate @ 3 mg 3-5 ml/h</intervention_name>
    <arm_group_label>Bupivacaine, Morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h</intervention_name>
    <arm_group_label>Bupivacaine, Fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing spine fusion surgery.

        Exclusion Criteria:

          -  Drug addiction. Intraoperative dural tear. Uses of opioids drug for any reason in the
             previous 48 hours. Mental dysfunction. Spinal fusion for any infectious or malignant
             causes.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omnia A Abd El Raof, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 24, 2013</lastchanged_date>
  <firstreceived_date>April 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Omnia Askar</investigator_full_name>
    <investigator_title>assistant lecturer of anesthesia and ICU, Assiut University</investigator_title>
  </responsible_party>
  <keyword>postoperative</keyword>
  <keyword>spine surgery</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
